76 results were returned
International law firm Bird & Bird today expands its Intellectual Property practice with the appointment of patent litigation specialist José Miguel Lissén Arbeloa as a partner in Madrid.
On 26 August 2019, China's National People's Congress passed the final amendments to the Drug Administration Law ("DAL"), which will take effect on 1 December 2019. The DAL was first enacted in 1984, then substantively ...
The NMPA issued the Drug Smart Supervision Plan aiming to deepen the development of a drug supervision system embracing modern information technologies such as cloud computing, big data, and "Internet+" technologies.
The Intellectual Property Enterprise Court (IPEC) has held that a patent was invalid but also considered a possible defence to infringement by equivalence.
On 20 April 2019, the Standing Committee of the National People's Congress ("NPC") held a second deliberation meeting to discuss the Draft Amendments to Drug Administration Law ("Second Draft DAL Amendments"). A week ...
The English Court of Appeal has today handed down its decision in the dispute between pharmaceutical companies, Merck KGaA, Darmstadt, Germany, and US-based Merck Sharp & Dohme Corp (MSD) for breach of contract and ...